Investigating the Immune System in chrONIC Kidney Disease.

NCT02535052 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2016-05-16

No results posted yet for this study

Summary

This study will investigate the function of the immune system in people with chronic kidney disease (CKD) compared to people with normal kidneys. The investigators will use standard vaccines - the seasonal flu vaccine and pneumococcal polysaccharide (Pneumovax) vaccine - to examine how the immune system responds to challenge. All subjects will receive these recommended vaccines as part of routine care. Blood and urine samples will be collected and tested at different time points to look at how the immune response develops to these vaccines and if there are any differences between people with CKD and those without. This will help us understand how CKD affects the function of the immune system.

Conditions

Interventions

BIOLOGICAL

Seasonal influenza and pneumococcal polysaccharide vaccines

Vaccination

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER
  • University Hospital Birmingham NHS Foundation Trust

    collaborator OTHER
  • University of Birmingham

    lead OTHER

Principal Investigators

  • Lorraine Harper · University of Birmingham

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02535052 on ClinicalTrials.gov